Literature DB >> 14136243

THE GALACTOSE ELIMINATION CAPACITY IN CONTROL SUBJECTS AND IN PATIENTS WITH CIRRHOSIS OF THE LIVER.

N TYGSTRUP.   

Abstract

Entities:  

Keywords:  CARBOHYDRATE METABOLISM; GALACTOSE; LIVER CIRRHOSIS; LIVER FUNCTION TESTS

Mesh：

Substances：

Year:  1964        PMID： 14136243     DOI： 10.1111/j.0954-6820.1964.tb00576.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  22 in total

1.  13C breath test for measurement of liver function.

Authors:  M Becker
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

2.  Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2011-04-12       Impact factor: 3.584

3.  The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

Authors:  N R Scott; D Stambuk; J Chakraborty; V Marks; M Y Morgan
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

4.  A method of measuring quantitative hepatic function and hemodynamics in cirrhosis: the changes following distal splenorenal shunt.

Authors:  J M Henderson; W D Warren
Journal:  Jpn J Surg       Date:  1986-05

5.  [Hepatic galactose elimination lapacity in chronic renal insufficiency (author's transl)].

Authors:  H Wernze; F Wagner
Journal:  Klin Wochenschr       Date:  1973-09-15

6.  Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations.

Authors:  E Garello; S Battista; F Bar; G A Niro; N Cappello; M Rizzetto; G Molino
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

7.  Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin.

Authors:  Tatsuyuki Tonan; Kiminori Fujimoto; Aliya Qayyum; Sanae Azuma; Masatoshi Ishibashi; Takato Ueno; Noriyuki Ono; Junji Akiyoshi; Sunao Matsushita; Naofumi Hayabuchi; Takumi Kawaguchi; Michio Sata
Journal:  Exp Ther Med       Date:  2011-04-11       Impact factor: 2.447

Review 8.  A review of new approaches to assessing hepatic function in animals.

Authors:  C E Cornelius
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

9.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

10.  Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial.

Authors:  L F Rikkers; D A Burnett; G D Volentine; K N Buchi; R A Cormier
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.